News from 3-v biosciences, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 04, 2013, 08:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Commences Patient Dosing in Phase 1 Clinical Study of FASN Inhibitor TVB-2640 in Patients with Advanced Solid Tumors

 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and...

Nov 21, 2013, 08:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Names Dr. William McCulloch Chief Medical Officer

 3-V Biosciences, Inc. (3-V), a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and...

Oct 21, 2013, 12:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

 3-V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key host-cell pathways resulting in death of tumor...

Jun 21, 2013, 08:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Completes $20 Million Series C Financing

3-V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, today...

Nov 10, 2012, 09:01 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012

 3-V Biosciences, Inc., announced today that preclinical data for its novel fatty acid synthase (FASN) inhibitors for the treatment of chronic...

Oct 01, 2012, 09:15 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences To Present Data on HCV Product Candidates at the American Association for the Study of Liver Disease Annual Meeting 2012

3-V Biosciences, Inc., announced today that two abstracts have been accepted for presentation at the 63rd Annual Meeting of the American...

Jul 10, 2012, 09:15 ET

3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference

3-V Biosciences, Inc., announced today that George Kemble, PhD, Chief Scientific Officer, will present at the upcoming JMP Securities Healthcare...

Jun 29, 2012, 09:15 ET

3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology

 3-V Biosciences, Inc., announced today the appointment of Douglas Buckley, PhD, as Vice President of Biology.  Dr. Buckley brings...

Jan 05, 2012, 09:15 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Closes Preferred Stock Financing and Designates Novel Host-Factor Hepatitis C Program

      3-V Biosciences, Inc. announced today both the closing of a Preferred Stock financing and the designation of a novel...

Aug 15, 2011, 09:45 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer

3-V Biosciences, Inc. announced today the appointment of George W. Kemble, PhD as Chief Scientific Officer. "We are very pleased to have George...

Feb 10, 2011, 09:15 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer

3-V Biosciences, Inc. announced today Stephen R. Brady has been named as Chief Business Officer.   "Steve's contributions have been...

Sep 30, 2010, 09:15 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer

3-V Biosciences, Inc. announced today the appointment of Merdad V. Parsey, MD, PhD as Chief Executive Officer.   (...

Jul 20, 2010, 09:15 ET

James F. Young Joins 3-V Biosciences Board of Directors

3-V Biosciences, Inc. today announced the appointment of James F. Young, Ph.D. to its Board of Directors.   "We are very pleased to...

Jun 03, 2010, 09:15 ET

3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer

3-V Biosciences, Inc. announced today the appointment of Edward M. Connor, Jr., MD, as Chief Medical Officer. "Ed Connor is among the most...

May 13, 2010, 08:30 ET
A F BGRMODS, LLC INTENSAFIRE BGRMODS, LLC INTENSAFIRE

BGRMods adds PS3 IntensaFIRE to line-up. (PRNewsFoto/BGRMods, LLC)[TK]
 DULUTH, MN UNITED STATES
 05/13/2010

3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations

3-V Biosciences, Inc. announced today the appointment of Stephen R. Brady to the post of Vice President, Corporate Development, Strategy...